BiotechTube

ASP8062 + Placebo

Phase 2Completed
1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fibromyalgia

Conditions

Fibromyalgia

Trial Timeline

May 8, 2017 → Mar 6, 2018

NCT ID
NCT03092726

About ASP8062 + Placebo

ASP8062 + Placebo is a phase 2 stage product being developed by Astellas Pharma for Fibromyalgia. The current trial status is completed. This product is registered under clinical trial identifier NCT03092726. Target conditions include Fibromyalgia.

What happened to similar drugs?

11 of 20 similar drugs in Fibromyalgia were approved

Approved (11) Terminated (3) Active (9)
✅zonisamideEisaiApproved
✅DuloxetineEli LillyApproved
✅duloxetine hydrochloride + placeboEli LillyApproved
✅Duloxetine + PlaceboEli LillyApproved
✅Eszopiclone + placeboSumitomo PharmaApproved
✅QuetiapineAstraZenecaApproved
✅amitriptyline + quetiapineAstraZenecaApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT05096117Phase 2Completed
NCT03183739Phase 1Completed
NCT03092726Phase 2Completed

Competing Products

20 competing products in Fibromyalgia

See all competitors
ProductCompanyStageHype Score
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
DS-5565Daiichi SankyoPhase 3
40
DS-5565 + PlaceboDaiichi SankyoPhase 3
40
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
ASP0819 + PlaceboAstellas PharmaPhase 2
35
DuloxetineShionogiPhase 3
40
Duloxetine 60 mg + PlaceboShionogiPhase 3
40
zonisamideEisaiApproved
35
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
42
DuloxetineEli LillyApproved
35
duloxetine hydrochloride + placeboEli LillyApproved
43
duloxetineEli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyApproved
43
Treatment for FibromyalgiaEli LillyPre-clinical
26
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
Eszopiclone + placeboSumitomo PharmaApproved
43